Astrazeneca annual free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Astrazeneca Free Cash Flow (FCF) History (AZN)
Astrazeneca reported $11.77B in free cash flow for fiscal 2025, an increase of 18.40% from the previous fiscal year, with a free cash flow margin of 20.03%.
View full Astrazeneca company overviewAstrazeneca free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.77B | $1.83B | +18.40% | +20.03% |
| 2024 | 2024-12-31 | $9.94B | $953.0M | +10.61% | +18.38% |
| 2023 | 2023-12-31 | $8.98B | $267.0M | +3.06% | +19.61% |
| 2022 | 2022-12-31 | $8.72B | $3.85B | +78.92% | +19.65% |
| 2021 | 2021-12-31 | $4.87B | $1.03B | +26.94% | +13.02% |
| 2020 | 2020-12-31 | $3.84B | $1.85B | +92.86% | +14.42% |
| 2019 | 2019-12-31 | $1.99B | $415.0M | +26.35% | +8.16% |
| 2018 | 2018-12-31 | $1.57B | −$677.0M | −30.06% | +7.13% |
| 2017 | 2017-12-31 | $2.25B | −$447.0M | −16.56% | +10.02% |
| 2016 | 2016-12-31 | $2.70B | $703.0M | +35.22% | +11.73% |
| 2015 | 2015-12-31 | $2.00B | — | — | +8.08% |
Astrazeneca quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Astrazeneca free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $3.84B to $11.77B, a compound annual growth rate of 25.11%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Astrazeneca filings at SEC.gov ↗